Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
Details for Australian Patent Application No. 2003298939 (hide)
International Classifications
Event Publications
6 May 2004 Complete Application Filed
Priority application(s): 60/431,650 06.12.02 US
5 August 2004 Application Open to Public Inspection
Published as AU-B-2003298939
15 March 2007 Application Accepted
Published as AU-B-2003298939
3 May 2007 Change of Name(s) of Applicant(s), Section 104
North Shore-Long Island Jewish Research Institute The name of the applicant has been changed to The Feinstein Institute for Medical Research Change of Name(s) of Applicant(s), Section 104
28 June 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 28 May 2007. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000 2004
19 July 2007 Standard Patent Sealed
8 November 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 28 May 2007 2004
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser